Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 1999 Nov; 81(5): 814–821.
PMCID: PMC2374300

New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis


A new human hepatocellular carcinoma (HCC) cell line with a highly metastatic potential was established from subcutaneous xenograft of a metastatic model of human HCC in nude mice (LCI-D20) by means of alternating cell culture in vitro and growth in nude mice. The line, designated MHCC97, has been cultivated for 18 months and subcultured for more than 90 passages. The line was showed to be of human origin by karyotype analysis. The cells were either grown as compact colonies (in clusters) or as a monolayered sheet with about 31 h of population-doubling time, exhibited typical malignant epithelial in morphology and were positive for α-fetoprotein (AFP). Flow cytometric analysis of the cell DNA content showed an aneuploid pattern, and its index was 1.5 as compared to that of normal human peripheral blood lymphocytes. Karyotypic analyses of G- and C-banding techniques revealed that all cells presented chromosome abnormalities in number and structure. The number of cell line MHCC97 chromosome ranged from 59 to 65 with a modal number of 60 and 61. At least two common chromosome markers, i(1q) and der(4)t(4;?)(4pter→q35::?), were present in all cells, and deletion of Y chromosome also occurred in all cells. The subcutaneous and intrahepatic xenografts were formed and metastatic lesions in lungs were found after the cells were inoculated into nude mice. The rate of metastasis to lungs was 100% using orthotopic inoculation. Reverse transcription polymerase chain reaction products revealed positive expressions of integrin α5 and β1, urokinase type plasminogen activator receptor (uPAR), vascular endothelial growth factor and nm23-H1 mRNAs of cell line MHCC97. Immunostaining of c-Met, uPAR showed strongly positive in both subcutaneous xenografts and lung metastatic lesions; while positive in xenografts and negative in metastatic lesions for integrin α5, β1. E-cadherin and P53 was not expressed either in xenograft or in the metastatic lesions. PCR products of HBsAg and HBxAg were both positive. The cell line MHCC97 still retained some characteristic features of original tumour. Establishment of cell line MHCC97 should be beneficial to the studies of HCC metastatic mechanisms. © 1999 Cancer Research Campaign

Keywords: hepatocellular carcinoma, establishment, cell culture, cell line, metastasis, metastasis-associated factors

Full Text

The Full Text of this article is available as a PDF (406K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest. 1993 Jan;68(1):4–17. [PubMed]
  • Alexander JJ, Bey EM, Geddes EW, Lecatsas G. Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J. 1976 Dec 18;50(54):2124–2128. [PubMed]
  • Amadori D, Bertoni L, Flamigni A, Savini S, De Giovanni C, Casanova S, De Paola F, Amadori A, Giulotto E, Zoli W. Establishment and characterization of a new cell line from primary human breast carcinoma. Breast Cancer Res Treat. 1993 Dec;28(3):251–260. [PubMed]
  • Anderson BB, Ukah F, Tette A, Villaflor SG, Koh D, Seton P. Primary tumors of the liver. J Natl Med Assoc. 1992 Feb;84(2):129–135. [PMC free article] [PubMed]
  • Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA. Molecular aspects of tumor cell invasion and metastasis. Cancer. 1993 Feb 15;71(4):1368–1383. [PubMed]
  • Bardi G, Johansson B, Pandis N, Heim S, Mandahl N, Andrén-Sandberg A, Hägerstrand I, Mitelman F. Cytogenetic findings in three primary hepatocellular carcinomas. Cancer Genet Cytogenet. 1992 Feb;58(2):191–195. [PubMed]
  • Bishop JM. Molecular themes in oncogenesis. Cell. 1991 Jan 25;64(2):235–248. [PubMed]
  • Blasi F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays. 1993 Feb;15(2):105–111. [PubMed]
  • Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992 Nov;119(3):629–641. [PMC free article] [PubMed]
  • Chen HL, Chiu TS, Chen PJ, Chen DS. Cytogenetic studies on human liver cancer cell lines. Cancer Genet Cytogenet. 1993 Feb;65(2):161–166. [PubMed]
  • CH'EN JM. The establishment of a strain of human liver cell carcinoma in vitro and some preliminary observations. Chin Med J. 1963 Apr;82:228–237. [PubMed]
  • Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F, Comoglio PM. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 1992 Dec;11(13):4825–4833. [PMC free article] [PubMed]
  • Ellis V, Pyke C, Eriksen J, Solberg H, Danø K. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann N Y Acad Sci. 1992 Dec 4;667:13–31. [PubMed]
  • Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 1994 Oct 21;79(2):185–188. [PubMed]
  • Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D, Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991 Apr;113(1):173–185. [PMC free article] [PubMed]
  • Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, et al. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 1991 Jan 1;51(1):89–93. [PubMed]
  • Giancotti FG, Ruoslahti E. Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell. 1990 Mar 9;60(5):849–859. [PubMed]
  • Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973 Nov;51(5):1417–1423. [PubMed]
  • Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1937–1941. [PMC free article] [PubMed]
  • Hambly RJ, Double JA, Thompson MJ, Bibby MC. Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude mice. Breast Cancer Res Treat. 1997 May;43(3):247–258. [PubMed]
  • He L, Isselbacher KJ, Wands JR, Goodman HM, Shih C, Quaroni A. Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro. 1984 Jun;20(6):493–504. [PubMed]
  • Hsu T, Möröy T, Etiemble J, Louise A, Trépo C, Tiollais P, Buendia MA. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell. 1988 Nov 18;55(4):627–635. [PubMed]
  • Igawa M, Rukstalis DB, Tanabe T, Chodak GW. High levels of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res. 1994 Mar 1;54(5):1313–1318. [PubMed]
  • Jeffers M, Rong S, Vande Woude GF. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol. 1996 Mar;16(3):1115–1125. [PMC free article] [PubMed]
  • Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994 Apr 15;152(8):4149–4156. [PubMed]
  • Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 1981 May;41(5):1657–1663. [PubMed]
  • Kuroki T, Fujiwara Y, Nakamori S, Imaoka S, Kanematsu T, Nakamura Y. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cancer. 1995 Aug;72(2):383–385. [PMC free article] [PubMed]
  • Liao SK, Dent PB, McCulloch PB. Characterization of human maligant melanoma cell lines. I. Morphology and growth characteristics in culture. J Natl Cancer Inst. 1975 May;54(5):1037–1044. [PubMed]
  • Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem. 1996 Apr;119(4):591–600. [PubMed]
  • Meltzer P, Leibovitz A, Dalton W, Villar H, Kute T, Davis J, Nagle R, Trent J. Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. Br J Cancer. 1991 May;63(5):727–735. [PMC free article] [PubMed]
  • Miyasaka M. Cancer metastasis and adhesion molecules. Clin Orthop Relat Res. 1995 Mar;(312):10–18. [PubMed]
  • Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 1991 Oct 15;51(20):5520–5525. [PubMed]
  • Nigam AK, Pignatelli M, Boulos PB. Current concepts in metastasis. Gut. 1994 Jul;35(7):996–1000. [PMC free article] [PubMed]
  • Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K, Yamaoka Y, Ikenaga M, Imura H, Ishizaki K. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer. 1992 Jul 30;51(6):862–868. [PubMed]
  • Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 1992 May;15(5):948–963. [PubMed]
  • Park JG, Frucht H, LaRocca RV, Bliss DP, Jr, Kurita Y, Chen TR, Henslee JG, Trepel JB, Jensen RT, Johnson BE, et al. Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 1990 May 1;50(9):2773–2780. [PubMed]
  • Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993 Jun 19;54(4):594–606. [PubMed]
  • Pasquinelli C, Garreau F, Bougueleret L, Cariani E, Grzeschik KH, Thiers V, Croissant O, Hadchouel M, Tiollais P, Bréchot C. Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors. J Virol. 1988 Feb;62(2):629–632. [PMC free article] [PubMed]
  • Rogler CE, Sherman M, Su CY, Shafritz DA, Summers J, Shows TB, Henderson A, Kew M. Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. Science. 1985 Oct 18;230(4723):319–322. [PubMed]
  • Schreiner C, Fisher M, Hussein S, Juliano RL. Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res. 1991 Mar 15;51(6):1738–1740. [PubMed]
  • Seabright M. A rapid banding technique for human chromosomes. Lancet. 1971 Oct 30;2(7731):971–972. [PubMed]
  • Shimoyama Y, Hirohashi S. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett. 1991 May 1;57(2):131–135. [PubMed]
  • Simon D, Munoz SJ, Maddrey WC, Knowles BB. Chromosomal rearrangements in a primary hepatocellular carcinoma. Cancer Genet Cytogenet. 1990 Apr;45(2):255–260. [PubMed]
  • Simon D, Knowles BB, Weith A. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene. 1991 May;6(5):765–770. [PubMed]
  • Sugimura T. Multistep carcinogenesis: a 1992 perspective. Science. 1992 Oct 23;258(5082):603–607. [PubMed]
  • Sun FX, Tang ZY, Lui KD, Ye SL, Xue Q, Gao DM, Ma ZC. Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer. 1996 Apr 10;66(2):239–243. [PubMed]
  • Tom BH, Rutzky LP, Oyasu R, Tomita JT, Goldenberg DM, Kahan BD. Human colon adenocarcinoma cells. II. Tumorigenic and organoid expression in vivo and in vitro. J Natl Cancer Inst. 1977 May;58(5):1507–1512. [PubMed]
  • Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 1990 Nov;111(5 Pt 1):2097–2108. [PMC free article] [PubMed]
  • Weinberg RA. The integration of molecular genetics into cancer management. Cancer. 1992 Sep 15;70(6 Suppl):1653–1658. [PubMed]
  • Werner M, Nolte M, Georgii A, Klempnauer J. Chromosome 1 abnormalities in hepatocellular carcinoma. Cancer Genet Cytogenet. 1993 Apr;66(2):130–130. [PubMed]
  • Yeh SH, Chen PJ, Chen HL, Lai MY, Wang CC, Chen DS. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res. 1994 Aug 1;54(15):4188–4192. [PubMed]
  • Yeh SH, Chen PJ, Lai MY, Chen DS. Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production. Gastroenterology. 1996 Jan;110(1):184–192. [PubMed]
  • Zhang WD, Hirohashi S, Tsuda H, Shimosato Y, Yokota J, Terada M, Sugimura T. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res. 1990 Feb;81(2):108–111. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...